Cargando…

Feasibility of conducting a randomized, placebo-controlled study assessing whether omega-3 fatty acids prevent gout flares when starting urate-lowering treatment

OBJECTIVE: The aim was to test the feasibility of a randomized controlled trial exploring whether omega-3 fatty acid supplementation limits gout flares during treat-to-target urate-lowering treatment (T2T-ULT). METHODS: Adults with at least one gout flare in the past 12 months and serum urate (SU) ≥...

Descripción completa

Detalles Bibliográficos
Autores principales:	Abhishek, Abhishek, Fuller, Amy, Nakafero, Georgina, Zhang, Weiya, Dumbleton, Jennifer, Hawkey, Christopher, Coupland, Carol, Terkeltaub, Robert, Doherty, Michael
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Oxford University Press 2022
Materias:	Original Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9667976/ https://www.ncbi.nlm.nih.gov/pubmed/36407800 http://dx.doi.org/10.1093/rap/rkac086

Ejemplares similares

Effect of omega-three supplementation on serum urate and gout flares in people with gout; a pilot randomized trial
por: Stamp, Lisa K., et al.
Publicado: (2022)

Brief Report: Monosodium Urate Monohydrate Crystal Deposits Are Common in Asymptomatic Sons of Patients With Gout: The Sons of Gout Study
por: Abhishek, Abhishek, et al.
Publicado: (2018)

Implication of nurse intervention on engagement with urate-lowering drugs: A qualitative study of participants in a RCT of nurse led care
por: Latif, Zahira P., et al.
Publicado: (2019)

Fluctuation and change of serum urate levels and flares in gout: results from the NOR-Gout study
por: Uhlig, T., et al.
Publicado: (2022)

Association between inactivated influenza vaccine and primary care consultations for autoimmune rheumatic disease flares: a self-controlled case series study using data from the Clinical Practice Research Datalink
por: Nakafero, Georgina, et al.
Publicado: (2019)

Elevated serum CA72-4 predicts gout flares during urate lowering therapy initiation: a prospective cohort study
por: Hu, Shuhui, et al.
Publicado: (2022)

The Effect of Decrease in Serum Urate for the Risk of Gout Flares During Urate-Lowering Therapy Initiation Among Chinese Male Gout Patients: A Prospective Cohort Study
por: Pang, Lei, et al.
Publicado: (2023)

When underlying biology threatens the randomization principle — initial gout flares of urate-lowering therapy
por: Choi, Hyon K., et al.
Publicado: (2022)

Triggers of acute attacks of gout, does age of gout onset matter? A primary care based cross-sectional study
por: Abhishek, Abhishek, et al.
Publicado: (2017)

Urate-lowering treatment and risk of total joint replacement in patients with gout
por: Kuo, Chang-Fu, et al.
Publicado: (2018)

Integrated safety studies of the urate reabsorption inhibitor lesinurad in treatment of gout
por: Terkeltaub, Robert, et al.
Publicado: (2019)

Rheumatoid arthritis and excess mortality: down but not out. A primary care cohort study using data from Clinical Practice Research Datalink
por: Abhishek, Abhishek, et al.
Publicado: (2018)

Monosodium urate burden assessed with dual-energy computed tomography predicts the risk of flares in gout: a 12-month observational study: MSU burden and risk of gout flare
por: Pascart, Tristan, et al.
Publicado: (2018)

Efficacy and cost-effectiveness of nurse-led care involving education and engagement of patients and a treat-to-target urate-lowering strategy versus usual care for gout: a randomised controlled trial
por: Doherty, Michael, et al.
Publicado: (2018)

Positive association of tomato consumption with serum urate: support for tomato consumption as an anecdotal trigger of gout flares
por: Flynn, Tanya J, et al.
Publicado: (2015)

Gout during the SARS-CoV-2 pandemic: increased flares, urate levels and functional improvement
por: García-Maturano, Juan Salvador, et al.
Publicado: (2021)

Is vaccination against COVID-19 associated with autoimmune rheumatic disease flare? A self-controlled case series analysis
por: Nakafero, Georgina, et al.
Publicado: (2022)

Do β-adrenoreceptor blocking drugs associate with reduced risk of symptomatic osteoarthritis and total joint replacement in the general population? A primary care-based, prospective cohort study using the Clinical Practice Research Datalink
por: Nakafero, Georgina, et al.
Publicado: (2019)

Are polymorphisms affecting serum urate, renal urate handling and alcohol intake associated with co-morbidities in gout cases? A case–control study using data from the UK Biobank
por: Sandoval-Plata, Gabriela, et al.
Publicado: (2022)

Urate in fingernail represents the deposition of urate burden in gout patients
por: Chen, Haibing, et al.
Publicado: (2020)

Gout. Novel therapies for treatment of gout and hyperuricemia
por: Terkeltaub, Robert
Publicado: (2009)

Variation in serum urate levels in the absence of gout and urate lowering therapy
por: Shaffer, Andrew, et al.
Publicado: (2021)

Reasons for discontinuing urate-lowering treatment in community-dwelling adults with gout: results of a primary care-based cross-sectional study
por: Elmelegy, Dalia, et al.
Publicado: (2021)

Decrease in Serum Urate Level Is Associated With Loss of Visceral Fat in Male Gout Patients
por: Ran, Zijing, et al.
Publicado: (2021)

Predictors and temporal trend of flu vaccination in auto-immune rheumatic diseases in the UK: a nationwide prospective cohort study
por: Nakafero, Georgina, et al.
Publicado: (2018)

Effectiveness of inactivated influenza vaccine in autoimmune rheumatic diseases treated with disease-modifying anti-rheumatic drugs
por: Nakafero, Georgina, et al.
Publicado: (2020)

β-blocker prescription is associated with lower cumulative risk of knee osteoarthritis and knee pain consultations in primary care: a propensity score–matched cohort study
por: Nakafero, Georgina, et al.
Publicado: (2021)

Colchicine prophylaxis is associated with fewer gout flares after COVID-19 vaccination
por: Lu, Jie, et al.
Publicado: (2022)

What is the incidence of methotrexate or leflunomide discontinuation related to cytopenia, liver enzyme elevation or kidney function decline?
por: Nakafero, Georgina, et al.
Publicado: (2021)

Adherence with urate-lowering therapies for the treatment of gout
por: Harrold, Leslie R, et al.
Publicado: (2009)

Systemic Urate Deposition: An Unrecognized Complication of Gout?
por: Khanna, Puja, et al.
Publicado: (2020)

Urate‐lowering therapy for patients with gout on hemodialysis
por: Alkilany, Reem, et al.
Publicado: (2022)

Incident gout and erectile dysfunction: is hyperuricaemia the elephant in the room?
por: Abhishek, Abhishek, et al.
Publicado: (2017)

Using serum urate as a validated surrogate end point for flares in patients with gout: protocol for a systematic review and meta-regression analysis
por: Morillon, Melanie B, et al.
Publicado: (2016)

Gout Activity Score has predictive validity and is sensitive to change: results from the Nottingham Gout Treatment Trial (Phase II)
por: Chinchilla, Sandra P, et al.
Publicado: (2019)

Development and validation of a prognostic model for leflunomide discontinuation with abnormal blood tests during long-term treatment: cohort study using data from the Clinical Practice Research Datalink Gold and Aurum
por: Nakafero, Georgina, et al.
Publicado: (2021)

The relationship between ferritin and urate levels and risk of gout
por: Fatima, Tahzeeb, et al.
Publicado: (2018)

Coevolution of URAT1 and Uricase during Primate Evolution: Implications for Serum Urate Homeostasis and Gout
por: Tan, Philip K., et al.
Publicado: (2016)

Early urate-lowering therapy in gouty arthritis with acute flares: a double-blind placebo controlled clinical trial
por: Yang, Deng-Ho, et al.
Publicado: (2023)

Purinergic Signaling in the Regulation of Gout Flare and Resolution
por: Li, Xiaoling, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_2h8od9ianuck23qsjpnnnm8omi